Shuai Wang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Long Non Coding Rna

Top Venues

Molecular pharmaceutics

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Luyao Ma, Wanying Zeng, Zhiyi Tan, Rui Wang, Yi Yang, Shubin Lin, Feng Li, Shuai Wang
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition. Molecular pharmaceutics 20 (2) (2022)
Luyao Ma, Wanying Zeng, Zhiyi Tan, Rui Wang, Yi Yang, Shubin Lin, Feng Li, Shuai Wang
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition. Molecular pharmaceutics 20 (2) (2022)
Luyao Ma, Wanying Zeng, Zhiyi Tan, Rui Wang, Yi Yang, Shubin Lin, Feng Li, Shuai Wang
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition. Molecular pharmaceutics (2022)
Luyao Ma, Wanying Zeng, Zhiyi Tan, Rui Wang, Yi Yang, Shubin Lin, Feng Li, Shuai Wang
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition. Molecular pharmaceutics 20 (2) (2022)
Shuai Wang, Yanke Lin, Feng Li, Zifei Qin, Ziyue Zhou, Lu Gao, Zemin Yang, Zhigang Wang, Baojian Wu
An NF-κB-driven lncRNA orchestrates colitis and circadian clock. Science advances 6 (42) (2020)